EUVIMEDEUVIMED entdecken
Crossref

Biocompatibility And Osteogenic Assessment Of Copper Zinc Iron Oxide (CuZnFe₂O₄) Nanoparticles Intended For Bone Regeneration

Aashiq Mohamed, Saravanan Sekaran, Dhanraj Ganapathy

International Journal of Drug Delivery Technology · 13.04.2026 · 16 (9s)

DOI: 10.25258/ijddt.16.9s.25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 13.04.2026. Verfasst von Aashiq Mohamed und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Bone tissue engineering is emerging as a promising solution to address skeletal defects caused by trauma, disease, or aging. Conventional approaches such as autografts and allografts are limited by donor site morbidity, immune rejection, and availability. Nanoparticles, particularly magnetic nanoparticles like Copper Zinc Iron Oxide (CuZnFe₂O₄), are gaining attention due to their biocompatibility and potential to enhance osteogenic differentiation. Trace elements such as copper, zinc, and iron participate in bone metabolism, angiogenesis, and collagen synthesis, which makes CuZnFe₂O₄ nanoparticles an attractive material for bone regeneration. Thus, this study explores the biocompatibility and osteogenic potential of CuZnFe₂O₄ nanoparticles using mouse mesenchymal stem cells. Materials and Methods: Mouse MSCs (mesenchymal stem cells) were cultured with CuZnFe₂O₄ nanoparticles at various concentrations of 5-50 μg/mL. The cytotoxicity of the nanoparticles was measured with the MTT assay of mitochondrial activity and the LDH assay of membrane integrity after 24 hours. The osteogenic differentiation of cells was determined by the quantitative PCR of the expression levels of Runx2, ALP, and Col-I under osteogenic conditions for seven days. The analysis was done using one-way ANOVA. Results and Discussion: The CuZnFe₂O₄ nanoparticles were found to exhibit biocompatibility up to a concentration of 10 μg/mL, although minor cytotoxicity appeared in the MTT and LDH assays. Moreover, gene expression analysis showed elevated expression of Runx2, ALP, and Col-I under osteogenic conditions, thus indicating potential increased osteogenic differentiation capacity. The concentrations of >20 μg/mL show cytotoxicity, requiring further optimization for concentrations.

Conclusion

CuZnFe₂O₄ nanoparticles show excellent biocompatibility and osteogenic potential as a promising biomaterial for bone tissue engineering. Further, in vivo studies and long-term biocompatibility should be carried out to assess their clinical applicability.

Zitieren

APA

Mohamed, A., Sekaran, S., & Ganapathy, D. (2026). Biocompatibility And Osteogenic Assessment Of Copper Zinc Iron Oxide (CuZnFe₂O₄) Nanoparticles Intended For Bone Regeneration. International Journal of Drug Delivery Technology, 16(9s). https://doi.org/10.25258/ijddt.16.9s.25

Vancouver

Mohamed A, Sekaran S, Ganapathy D. Biocompatibility And Osteogenic Assessment Of Copper Zinc Iron Oxide (CuZnFe₂O₄) Nanoparticles Intended For Bone Regeneration. International Journal of Drug Delivery Technology. 2026;16(9s). doi:10.25258/ijddt.16.9s.25

BibTeX
@article{Mohamed2026,
  author = {Mohamed, Aashiq and Sekaran, Saravanan and Ganapathy, Dhanraj},
  title = {Biocompatibility And Osteogenic Assessment Of Copper Zinc Iron Oxide (CuZnFe₂O₄) Nanoparticles Intended For Bone Regeneration},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {9s},
  doi = {10.25258/ijddt.16.9s.25}
}
Kostenlos starten →